Related Experiment Video
Updated: Nov 6, 2025

03:38
Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
Published on: October 6, 2022
1.6K
Beyond small molecules: targeting G-quadruplex structures with oligonucleotides and their analogues
Enrico Cadoni1, Lessandro De Paepe1, Alex Manicardi1
1Organic and Biomimetic Chemistry Research Group, Ghent University, Krijgslaan 281 S4, B-9000 Ghent, Belgium.
Nucleic Acids Research
|May 12, 2021
Summary
This review explores G-quadruplexes (G4s), crucial DNA/RNA structures. It focuses on oligonucleotide-based probes, like LNAs and PNAs, for specific G4 targeting, an area with limited current approaches.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- G-quadruplexes (G4s) are vital secondary structures in G-rich DNA/RNA sequences.
- Their locations in critical genomic regions like proto-oncogenes and telomeres impact gene regulation.
- While small molecule stabilizers are numerous, sequence-specific G4 targeting probes are less developed.
Purpose of the Study:
- To review and analyze oligonucleotide-based strategies for G-quadruplex recognition and targeting.
- To highlight the potential of synthetic analogues like LNAs and PNAs in G4-specific applications.
- To provide a critical overview of current literature on G4-targeting probes.
Main Methods:
- Literature review of G-quadruplex targeting strategies.
- Analysis of oligonucleotide-based probes, including Locked Nucleic Acids (LNAs) and Peptide Nucleic Acids (PNAs).
- Critical evaluation of reported examples and their effectiveness in sequence-specific G4 recognition.
Main Results:
- Oligonucleotide-based probes offer a promising avenue for sequence-specific G4 targeting.
- LNAs and PNAs demonstrate potential as effective G4 recognition and binding agents.
- The field of synthetic probe-based G4 targeting is still evolving with room for advancement.
Conclusions:
- Oligonucleotide and synthetic analogues represent a key strategy for targeted G4 modulation.
- Further research into these probes can unlock new therapeutic and diagnostic applications for G4 structures.
- This review consolidates current knowledge and identifies future directions for G4-targeting probe development.
Related Concept Videos
Targets for Drug Action: Overview
8.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
8.5K
siRNA - Small Interfering RNAs
17.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.5K

